Which CRT patients can be ‘downgraded’ from a CRT-D device with defibrillator function to a CRT-P with just a pacemaker function? This, with two further current CRT issues – chronotropic incompetence and telemonitoring of CRT patients – featured prominently at the Europace-Cardiostim Congress in Vienna.
A formerly bitter competition between cardiology and cardiac surgery is increasingly replaced by constructive cooperation. The Austrian Society of Cardiology (ÖKG) even held its annual congress along with the Austrian Society of Thoracic and Cardiovascular Surgery this year.
Leading cardiologist and healthcare researcher Professor Harlan Krumholz has warned that medical practitioners must embrace the potential of digital data generated by patients if they are to avoid being left behind as the digital revolution moves forward at an ever-advancing pace
A pioneering study has certified that wearable technology produced better results in monitoring cardiac patients and improving their quality of life compared to conventional systems.
Coronary angioplasty is arguably the most revolutionary breakthrough in the history of cardiology. While the technique is today performed on millions of patients worldwide, its origins can be traced back to Zurich, Switzerland, in the late 1970s.
Celebrating 40 years of PCI, cardiologists fret over their future with big data, machine learning and robots.
With 4,500 accepted abstracts, 600 sessions and 30,000 expected attendees, ESC Congress 2017 is undoubtedly the world’s largest cardiovascular event. On healthcare-in-europe.com, Dr Stephan Achenbach, Congress Program Committee Chairperson, gives an overview of issues and events unfolding in Barcelona from August 26-30.
Researchers discover a new molecule, ‘Singheart’, that may hold the key to triggering the regeneration and repair of damaged heart cells.
Cardiac stem cell infusions could someday help reverse the aging process in the human heart, making older ones behave younger, according to a new study from the Cedars-Sinai Heart Institute.
Biotronik’s Home Monitoring is an award-winning remote cardiac monitoring system that automatically collects data from a patient’s cardiac device, enabling the physician to review cardiac function independently of in-office visits.
Cardiology in extreme environments takes centre stage at the British Cardiovascular Society (BCS) annual conference.
Professionals in the field of children’s cardiology will hold their world congress in FCB’s Camp Nou, Barcelona, Spain from the 16th to the 21st of July 2017. As part of the congress and for the first time, a special symposium will unite leading experts in the field of sports cardiology to discuss the heart health of the sports stars of the future.
Arteriogenesis is a critical event – not only during development but also in adult life. Many Cardiovascular life-threatening events could be overcome by inducing the formation of new arteries. A team of scientists led by Ralf Adams from the Max Planck Institute for Molecular Biomedicine has developed a genetic approach in mice to uncover molecular mechanisms of arterial growth.
The EASY PULSE® is an unbelievably small and light mechanical chest compression device. Performing manual chest compressions well for an extended period of time is almost impossible. Not only is it physically demanding, but other actions, such as vital signs monitoring, are also required simultaneously. SCHILLER’s EASY PULSE® is the solution for more efficient resuscitation: this portable,…
The ADVIA Centaur® High-Sensitivity Troponin I (TNIH) assay* is the latest addition to Siemens Healthineers’ comprehensive cardiac menu to assist clinicians with the diagnosis and treatment of chest pain patients. Designed to aid in diagnosing acute myocardial infarctions (AMI) through the quantitative measurement of cardiac troponin I in serum or plasma, high-sensitivity troponin plays a…
Breast implants may impede an electrocardiogram (ECG) and could result in a false heart attack diagnosis, according to research by the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC).
Researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have engineered a three-dimensional heart tissue from human stem cells to test the safety and efficacy of new drugs on the heart.
Cardiac surgeons are successfully performing more extensive surgical repairs of type A aortic dissection—one of the highest risk operations in cardiothoracic surgery. These new surgical techniques, along with improved postoperative care, are resulting in better long-term outcomes and lower rates of complications.
Researchers in Japan have identified a receptor protein on the surface of heart cells that promotes chronic heart failure. The study, “Corticotropin releasing hormone receptor 2 exacerbates chronic cardiac dysfunction” suggests that inhibiting this protein could help treat a disease that affects more than 20 million people worldwide.
Research published in Experimental Physiology shows that diabetes-induced changes in heartbeat are primarily regulated by the β1-adrenoceptor. This discovery, once confirmed in humans, may lead to better treatment of heart problems in diabetics by enabling more targeted drugs to be produced.
Researchers have found that people with A, B, and AB blood types may be at greater risk of cardiovascular events - particularly heart attack - than individuals with O blood types.
Researchers who studied beer drinkers at the Munich Oktoberfest have found that the more alcohol consumed the higher was the likelihood of developing abnormal heart rhythms called cardiac arrhythmias.
MBM ScienceBridge GmbH successfully negotiated a license agreement between Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin (UMG) and the biotech company Repairon GmbH about commercial production and use of engineered human myocardium for heart failure repair. The production methods are based on the scientific work from the group of Prof. Dr.…
Cardiology at the extremes will be the key theme at the British Cardiovascular Society annual conference in Manchester in June. Topics covered include reflections in cardiology and space travel, physiological challenges associated with living under extreme environmental conditions and polar expeditions. Report: Mark Nicholls
Space missions are famous for driving innovation, from Mylar blankets to microchips. So when French scientists learned one of their compatriots would be aboard the Soyuz MS-03 spacecraft to reach the International Space Station (ISS), they gathered cutting edge technologies for him to carry into orbit.
